• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » ResMed launches new patient-centric digital solutions for sleep apnea

ResMed launches new patient-centric digital solutions for sleep apnea

September 30, 2024 By Sean Whooley

ResMed MyAir Device
The MyAir consumer app. [Image courtesy of ResMed]
ResMed (NYSE: RMD) today announced new patient-centric products designed to enhance therapy for sleep apnea patients.

The new innovations from the sleep apnea therapy maker integrate with digital wearable devices and generative AI. San Diego-based ResMed said they aim to provide a more personalized sleep health experience while improving overall health. The company cited a recent survey that found that 54% of respondents expressed interest in a wearable device with sleep-tracking capabilities.

ResMed designed its latest innovations with digital wearables and the user experience in mind. It aims to offer personalized insights into sleep patterns and help users stay on track with their sleep therapy.

The company’s MyAir application helps patients stay engaged with their continuous positive airway pressure (CPAP) therapy. With interactive coaching and nightly sleep data tracking, MyAir helps increase CPAP usage, with 87% of patients achieving therapy compliance.

(ResMed also launched a new CPAP mask today — read about that HERE.)

Features for MyAir include a smartwatch app for both Apple and Android watches. This app allows users to monitor their therapy data at a glance and stay engaged with their therapy. Sleep staging data from Apple Health and Health Connect work with MyAir to provide a clearer understanding of sleep cycles.

ResMed also added personalized coaching for tips and strategies based on behavior science and machine learning. Its app delivers holistic trends, extending to tracked steps, energy burned, weight, blood oxygen, body mass index, daily exercise, heart rate variability, resting heart rate, time in bed, and total time asleep, from Apple Health and Health Connect along with CPAP therapy data, all in one place.

Additionally, ResMed offers a new, AI-enabled health concierge, called “Dawn.” It delivers instant, 24/7 access to answers about sleep health, ResMed products and CPAP therapy support. Using generative AI, Dawn offers personalized guidance and connects users with the information they need in real time.

“We know that digital wearables and other innovative technologies like AI can help consumers better understand their sleep habits and create a personalized pathway to better rest,” said Dr. Carlos M. Nunez, chief medical officer at ResMed. “Regular sleep tracking can offer crucial insights that empower people to make informed decisions about improving their sleep quality both now and in the future.”

Filed Under: Artificial Intelligence (AI), Business/Financial News, Digital Health, Health Technology, Machine Learning (ML), Patient Monitoring, Respiratory, Software / IT Tagged With: ResMed, ResMed Inc.

More recent news

  • Zenflow nets $52M, Cook Medical deal for in-office enlarged prostate implant
  • Abbott to update CardioMEMS to allow patients to track pulmonary artery pressure
  • Wandercraft acquires exoskeleton rival Ekso Bionics
  • GE HealthCare to buy Sofie Biosciences in $945M radiopharmaceutical play
  • Carlsmed names chief product and AI officer as it claims CMS reimbursements

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy